Freedom Eye Limited - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Freedom Eye Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Freedom Eye Limited Formerly known as Solbec Pharmaceuticals Limited. The Group's principal activity is conducting pharmaceutical research and development. It is focused on the extraction, purification and clinical development of plant-derived pharmaceuticals. It continues to develop a compound called Coramsine, as potential therapy for the treatment of cancer and certain inflammatory medical conditions. The Group operates in Australia. At 5-Dec-2008, the Group formally changed its name to Freedom Eye Limited.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report